← All trials
NCT06284434
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 24, 2024
- Primary completion
- Apr 24, 2026
- Completion date
- Apr 24, 2026
- First posted
- Feb 29, 2024
- Last posted
- Jul 3, 2024
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shriners Hospitals for ChildrenLead sponsor
- Shriners Hospitals for ChildrenSponsor investigator
- Shriners Hospitals for ChildrenOfficial
- Shriners Hospitals for ChildrenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.